We are live on ! Find out more
Walleye Capital

Walleye Capital Portfolio holdings

AUM $24B
1-Year Est. Return 37.67%
This Fund
S&P 500
This Quarter Est. Return
+6.28%
1 Year Est. Return
+37.67%
3 Year Est. Return
+98.01%
5 Year Est. Return
+160%
10 Year Est. Return
AUM
$3.74B
AUM Growth
+$522M
Cap. Flow
+$560M
Cap. Flow %
14.98%
Top 10 Hldgs %
16.36%
Holding
2,890
New
823
Increased
552
Reduced
580
Closed
639

Sector Composition

Rank Sector Weight
1 Financials 10.6%
2 Healthcare 10.46%
3 Industrials 9.64%
4 Consumer Discretionary 7.06%
5 Technology 6.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WALDW icon
1051
Waldencast PLC Warrant
WALDW
$5.01M
$429K 0.01%
446,901
+211,358
+90% +$199K
AUPH icon
1052
Aurinia Pharmaceuticals
AUPH
$1.95B
$428K 0.01%
+34,586
New +$535K
PIIIW icon
1053
P3 Health Partners Inc Warrant
PIIIW
$126K
$428K 0.01%
269,273
+72,711
+37% +$71.1K
CHWY icon
1054
Chewy
CHWY
$9.54B
$427K 0.01%
+10,475
New +$476K
LCAAU
1055
DELISTED
L Catterton Asia Acquisition Corp Units
LCAAU
$427K 0.01%
43,289
+6,026
+16% +$59.6K
RCFA
1056
DELISTED
Perception Capital Corp. IV
RCFA
$426K 0.01%
+42,820
New +$423K
EVOJU
1057
DELISTED
Evo Acquisition Corp. Unit
EVOJU
$425K 0.01%
43,225
+801
+2% +$7.93K
AOD
1058
abrdn Total Dynamic Dividend Fund
AOD
$1.08B
$424K 0.01%
44,159
+10,248
+30% +$99.5K
OIH icon
1059
CALL
VanEck Oil Services ETF
OIH
$1.97B
$424K 0.01%
1,500
EGRX
1060
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$424K 0.01%
+8,576
New +$412K
WBX
1061
Wallbox
WBX
$76.7M
$421K 0.01%
1,649
+176
+12% +$46.7K
LXRX icon
1062
Lexicon Pharmaceuticals
LXRX
$1.03B
$420K 0.01%
+200,968
New +$557K
PBH icon
1063
Prestige Consumer Healthcare
PBH
$2.47B
$420K 0.01%
+7,926
New +$458K
SB icon
1064
Safe Bulkers
SB
$772M
$419K 0.01%
+88,000
New +$359K
TRDA icon
1065
Entrada Therapeutics
TRDA
$254M
$419K 0.01%
+44,652
New +$479K
BROGW
1066
DELISTED
Brooge Holdings Limited Warrant expiring 12/20/2024
BROGW
$417K 0.01%
1,099,204
+5,547
+0.5% +$2.43K
DXJ icon
1067
WisdomTree Japan Hedged Equity Fund
DXJ
$7.07B
$416K 0.01%
+6,499
New +$408K
RLYB icon
1068
Rallybio
RLYB
$84.7M
$416K 0.01%
+7,443
New +$616K
MACAU
1069
DELISTED
Moringa Acquisition Corp Units
MACAU
$414K 0.01%
42,000
SDACU
1070
DELISTED
Sustainable Development Acquisition I Corp. Unit
SDACU
$414K 0.01%
41,946
SGFY
1071
DELISTED
Signify Health, Inc.
SGFY
$414K 0.01%
+22,797
New +$327K
TSPQ
1072
DELISTED
TCW Special Purpose Acquisition Corp.
TSPQ
$414K 0.01%
42,468
-1,060
-2% -$10.3K
ARCH
1073
DELISTED
Arch Resources, Inc.
ARCH
$413K 0.01%
3,008
-8,025
-73% -$950K
BCAT icon
1074
BlackRock Capital Allocation Term Trust
BCAT
$1.61B
$412K 0.01%
24,890
-31,037
-55% -$545K
ESTA icon
1075
Establishment Labs
ESTA
$2.71B
$412K 0.01%
6,119
+228
+4% +$13.3K

Similar funds

Walleye Capital's Q1 2022 Portfolio in Review

As of Q1 2022, Walleye Capital held 2,890 positions worth $3.74B, up 16% from $3.22B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Walleye Capital deployed $560M of net new capital in Q1 2022, opening 823 new positions and adding to 552 existing holdings. Its largest new stake was Otis Worldwide: 278,870 shares worth $21.5M.

By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 8.5% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Expand Energy Corp Class A Warrants, an estimated $32.4M trimmed.

  • Walleye Capital's largest Q1 2022 buy was Otis Worldwide: 278,870 shares worth $21.5M.
  • Walleye Capital added most to Expand Energy Corp Class B Warrants in Q1 2022, an estimated $38.1M increase.
  • Walleye Capital's biggest Q1 2022 reduction was Expand Energy Corp Class A Warrants, cutting an estimated $32.4M.
  • Walleye Capital fully exited Rockwell Automation in Q1 2022, selling an estimated $19.6M.
  • Walleye Capital's ten largest holdings make up 16% of its $3.74B portfolio in Q1 2022.
  • Walleye Capital opened 823 new positions and closed 639 in Q1 2022.
  • Walleye Capital's portfolio value rose 16% quarter-over-quarter to $3.74B.

Based on Walleye Capital's 13F filing for Q1 2022, filed 16 May 2022.